Respimat
Appearance
![]() | This article needs to be updated.(August 2018) |
![]() | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (December 2010) |
Respimat, commonly referred to as Respimat SMI (SMI indicates "Soft Mist Inhaler") is an advanced drug delivery device in comparison to MDIs (metered-dose inhalers) or DPIs (dry powder inhalers) used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as Spiriva (tiotropium bromide) and Combivent (ipratropium bromde/albuterol).